These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
103 related items for PubMed ID: 10544539
1. [Effect of weight reduction on the clinical and hormonal condition of obese anovulatory women]. Hernández García IA, Gutiérrez Gutiérrez AM, Gallardo Lozano E. Ginecol Obstet Mex; 1999 Sep; 67():433-7. PubMed ID: 10544539 [Abstract] [Full Text] [Related]
2. Effect of hypocaloric diet plus sibutramine treatment on hormonal and metabolic features in overweight and obese women with polycystic ovary syndrome: a randomized, 24-week study. Florakis D, Diamanti-Kandarakis E, Katsikis I, Nassis GP, Karkanaki A, Georgopoulos N, Panidis D. Int J Obes (Lond); 2008 Apr; 32(4):692-9. PubMed ID: 18071341 [Abstract] [Full Text] [Related]
3. The impact of bariatric surgery on menstrual patterns. Teitelman M, Grotegut CA, Williams NN, Lewis JD. Obes Surg; 2006 Nov; 16(11):1457-63. PubMed ID: 17132411 [Abstract] [Full Text] [Related]
4. Reduction in hematocrit level after pioglitazone treatment is correlated with decreased plasma free testosterone level, not hemodilution, in women with polycystic ovary syndrome. Berria R, Gastaldelli A, Lucidi S, Belfort R, De Filippis E, Easton C, Brytzki R, Cusi K, Jovanovic L, DeFronzo R. Clin Pharmacol Ther; 2006 Aug; 80(2):105-14. PubMed ID: 16890572 [Abstract] [Full Text] [Related]
6. [Plasma levels of insulin and leptin in patients with morbid obesity and anorexia nervosa after weight loss or gain, respectively]. Escobar L, Freire JM, Girón JA, Vázquez JM, Pajares M, Ortego J, Gavilán I, Chover AJ, Carrasco M, Epinosa R, Marín F, Aguilar M. Rev Esp Med Nucl; 2000 Jun; 19(3):199-206. PubMed ID: 11062083 [Abstract] [Full Text] [Related]
7. Body composition and metabolic effects of a diet and exercise weight loss regimen on obese, HIV-infected women. Engelson ES, Agin D, Kenya S, Werber-Zion G, Luty B, Albu JB, Kotler DP. Metabolism; 2006 Oct; 55(10):1327-36. PubMed ID: 16979403 [Abstract] [Full Text] [Related]
8. Retention of estradiol negative feedback relationship to LH predicts ovulation in response to caloric restriction and weight loss in obese patients with polycystic ovary syndrome. van Dam EW, Roelfsema F, Veldhuis JD, Hogendoorn S, Westenberg J, Helmerhorst FM, Frölich M, Krans HM, Meinders AE, Pijl H. Am J Physiol Endocrinol Metab; 2004 Apr; 286(4):E615-20. PubMed ID: 14678951 [Abstract] [Full Text] [Related]
9. An RCT of metformin versus orlistat for the management of obese anovulatory women. Metwally M, Amer S, Li TC, Ledger WL. Hum Reprod; 2009 Apr; 24(4):966-75. PubMed ID: 19095663 [Abstract] [Full Text] [Related]
10. Beneficial effects of metformin in normoglycemic morbidly obese adolescents. Kay JP, Alemzadeh R, Langley G, D'Angelo L, Smith P, Holshouser S. Metabolism; 2001 Dec; 50(12):1457-61. PubMed ID: 11735093 [Abstract] [Full Text] [Related]
11. Exercise-induced reduction in obesity and insulin resistance in women: a randomized controlled trial. Ross R, Janssen I, Dawson J, Kungl AM, Kuk JL, Wong SL, Nguyen-Duy TB, Lee S, Kilpatrick K, Hudson R. Obes Res; 2004 May; 12(5):789-98. PubMed ID: 15166299 [Abstract] [Full Text] [Related]
12. Metabolic risk factors in formerly obese women--effects of a pronounced weight loss by gastric band operation compared with weight loss by diet alone. Ritt M, Piza H, Rhomberg M, Aigner F, Lechleitner M. Diabetes Obes Metab; 2005 May; 7(3):216-22. PubMed ID: 15811137 [Abstract] [Full Text] [Related]
13. Morbid obesity: evaluation of metabolic indexes after adjustable silicone gastric banding. Mariani LM, Marini MA, Veneziani A, Bertoli A, Lauro R. Acta Diabetol; 2003 Oct; 40 Suppl 1():S263-5. PubMed ID: 14618489 [Abstract] [Full Text] [Related]
14. Resting energy expenditure and fuel metabolism following laparoscopic adjustable gastric banding in severely obese women: relationships with excess weight lost. Galtier F, Farret A, Verdier R, Barbotte E, Nocca D, Fabre JM, Bringer J, Renard E. Int J Obes (Lond); 2006 Jul; 30(7):1104-10. PubMed ID: 16477271 [Abstract] [Full Text] [Related]
15. Effect of significant intermediate-term weight loss on serum leptin levels and body composition in severely obese subjects. Infanger D, Baldinger R, Branson R, Barbier T, Steffen R, Horber FF. Obes Surg; 2003 Dec; 13(6):879-88. PubMed ID: 14738675 [Abstract] [Full Text] [Related]
16. Plasma visfatin levels in normal weight women with polycystic ovary syndrome. Panidis D, Farmakiotis D, Rousso D, Katsikis I, Delkos D, Piouka A, Gerou S, Diamanti-Kandarakis E. Eur J Intern Med; 2008 Oct; 19(6):406-12. PubMed ID: 18848173 [Abstract] [Full Text] [Related]
17. Serum retinol-binding protein 4 is not increased in obesity or obesity-associated type 2 diabetes mellitus, but is reduced after relevant reductions in body fat following gastric bypass. Gómez-Ambrosi J, Rodríguez A, Catalán V, Ramírez B, Silva C, Rotellar F, Gil MJ, Salvador J, Frühbeck G. Clin Endocrinol (Oxf); 2008 Aug; 69(2):208-15. PubMed ID: 18081728 [Abstract] [Full Text] [Related]
18. Leptin concentrations do not correlate with fat mass nor with metabolic risk factors in morbidly obese females. García-Lorda P, Bulló M, Vilà R, del Mar Grasa M, Alemany M, Salas-Salvadó J. Diabetes Nutr Metab; 2001 Dec; 14(6):329-36. PubMed ID: 11853365 [Abstract] [Full Text] [Related]
19. Effects of a multidisciplinary inpatient intervention on body composition, aerobic fitness, and quality of life in severely obese girls and boys. Knöpfli BH, Radtke T, Lehmann M, Schätzle B, Eisenblätter J, Gachnang A, Wiederkehr P, Hammer J, Brooks-Wildhaber J. J Adolesc Health; 2008 Feb; 42(2):119-27. PubMed ID: 18207089 [Abstract] [Full Text] [Related]